Pfizer Inc. (PFE) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Track Pfizer Inc. (PFE) stock performance with short-term forecasts for 2025 and long-term PFE price prediction till 2050. Review historical trends, get analyst Buy/Sell/Hold ratings, and stay updated with the latest Pfizer Inc. headlines.
1 Month Prediction
$50.47 [92.56%]
3 Month Prediction
$53.06 [102.46%]
6 Month Prediction
$53.73 [105.01%]
1 Year Prediction
$50.59 [93.02%]
3 Year Prediction
$45.84 [74.89%]
5 Year Prediction
$40.84 [55.80%]
About Pfizer Inc.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology company, headquartered in Manhattan, New York City. The company develops and produces medicines and vaccines for various medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology.
Pfizer is one of those companies that generates the largest revenues in the pharmaceutical sector. In 2023 alone, Pfizer products such as Pfizer–BioNTech COVID-19 vaccine generated $11 billion in revenue, which was largest among other pharma products followed by apixaban and a pneumococcal conjugate vaccine, which made $6 billion each.
Pfizer operates its major manufacturing facilities in India, China, Japan, Ireland, Italy, Belgium, Germany, Singapore, and the United States
Pfizer Inc. (PFE) Historical Performance
IPO Date
Pfizer Inc. (NYSE:PFE) went public on 22 June, 1942.
Change
Since inception, PFE has increased by 5,838.20%. In the last 5 years, PFE has fallen from $29.20 to $26.21, a minor -10.23% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $50.72 and a low of $24.11.
52 Week Range
$24.48
$31.54
The current price $26.21 is near the 52-week low, which means that the stock is underbought.
PFE Stock Price History
Based on PFE stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the PFE stock has fallen from $24.84 - $31.34 to $26.09 - $26.43, which is down -9.49%. Currently, the stock follows downward trend.
Here, we have calculated stock range of PFE, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $24.84 - $31.34 | $28.21 | -2.7 | 1 Year Change |
| 2021 | $27.98 - $50.72 | $35.94 | 23.97 | 2 Year Change |
| 2022 | $38.48 - $45.9 | $43.13 | 48.77 | 3 Year Change |
| 2023 | $26.69 - $39.16 | $32.65 | 12.62 | 4 Year Change |
| 2024 | $24.11 - $29.17 | $26.52 | -8.53 | 5 Year Change |
| 2025 | $26.09 - $26.43 | $26.24 | -9.49 | 6 Year Change |
PFE Price Performance
6-Month Performance
PFE stock dropped by 4.39% in the last six months.
1-Year Performance
The stock has trended upwards by 8.72% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 38.28%.
5-Year Performance
In the last 5 years, the stock has gone down by 10.23%.
According to Pfizer Inc.'s historical data, below graph gives us the exact picture of how the PFE stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 2 years and a decline in 3 years.
2020
3.07% ↑
2021
66.70% ↑
2022
10.41% ↓
2023
41.26% ↓
2024
2.22% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Pfizer Inc. (PFE) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $17.76 B (Q4)
Revenue for Q4 ending 31st December, 2024 increased 0.36% compared to Q3 ending 30th September, 2024.
Annual Revenue: $63.63 B (1Y)
Revenue for trailing 12 months decreased 0.00% year over year from 31st December, 2024.
Market Capitalization
Pfizer Inc. has a market capitalization of $148.65B, which places PFE in the large-cap category.
Fundamental Analysis
EPS: $nan (Q4), $nan (1Y)
EPS decreased nan% since last quarter, and decreased nan% since last year.
Net Income: $410.00 M (Q4), $8.03 B (1Y)
Net Income decreased 90.82% since last quarter, and increased 279.00% since last year.
Free Cash Flow: $5.80 B (Q4), $9.84 B (1Y)
Free Cash Flow decreased 4.27% since last quarter, and increased 105.20% since last year.
Net Profit Margin: 2.31% (Q4), 12.62% (1Y)
Net Profit Margin decreased 90.85% since last quarter, and increased 279.01% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for PFE stock. These indicators help you understand Pfizer Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for PFE stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $26.18 |
| SMA50 | $26.13 |
| SMA200 | $26.97 |
| RSI | 51.40 |
| Beta | 0.54 |
SMA20 < Current Price
This signals PFE stock is in short-term bullish momentum.
SMA50 < Current Price
This signals PFE stock is in mid-term bullish momentum.
SMA200 > Current Price
This signals PFE stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for PFE stock is Neutral. Out of all indicators, 1 indicates bullish signals, 4 signals bearish trends and 4 gives neutral trends. The PFE stock forecast was last updated on 20 March, 2025.
Pfizer Inc. (PFE) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $50.69 by the end of 2025, and can reach around $56.05 to $54.29 in 2026. And, the long-term forecast suggests that the stock may further jump to $51.94 - $49.69 in 2028, and $40.32 - $38.08 by 2031. So, the PFE stock shows a strong upward trend in the next several years.
Short-term PFE Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $50.47 | 92.56% |
| 2025-05 | $53.32 | 103.43% |
| 2025-06 | $53.06 | 102.44% |
| 2025-07 | $55.35 | 111.18% |
| 2025-08 | $54.02 | 106.1% |
| 2025-09 | $53.73 | 105.0% |
| 2025-10 | $50.99 | 94.54% |
| 2025-11 | $51.48 | 96.41% |
| 2025-12 | $50.69 | 93.4% |
In 2025, the PFE stock price is expected to fluctuate between $50.47 and $55.35. According to the monthly forecast, the stock could rise to $50.69 by December 2024. If compared to the PFE's current price, the stock could gain 93.4% by the end of this year.
Long-term PFE Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $56.05 | $51.23 | $54.29 | 107.13% |
| 2027 | $52.70 | $45.35 | $52.96 | 102.06% |
| 2028 | $51.94 | $46.74 | $49.69 | 89.58% |
| 2029 | $52.83 | $43.13 | $44.82 | 71.0% |
| 2030 | $44.37 | $38.47 | $41.59 | 58.68% |
| 2031 | $40.32 | $37.03 | $38.08 | 45.29% |
| 2032 | $42.12 | $32.88 | $35.96 | 37.2% |
| 2033 | $37.41 | $32.85 | $31.36 | 19.65% |
| 2034 | $36.29 | $30.88 | $33.47 | 27.7% |
| 2035 | $34.12 | $25.36 | $28.44 | 8.51% |
| 2036 | $30.20 | $22.85 | $26.94 | 2.79% |
| 2037 | $28.06 | $22.51 | $24.40 | -6.91% |
| 2038 | $26.68 | $18.62 | $20.84 | -20.49% |
| 2039 | $24.04 | $16.63 | $18.00 | -31.32% |
| 2040 | $20.18 | $14.39 | $16.46 | -37.2% |
| 2041 | $17.60 | $11.49 | $13.05 | -50.21% |
| 2042 | $16.67 | $9.49 | $11.36 | -56.66% |
| 2043 | $13.64 | $7.01 | $8.74 | -66.65% |
| 2044 | $10.20 | $4.60 | $6.12 | -76.65% |
| 2045 | $7.78 | $1.76 | $3.45 | -86.84% |
| 2046 | $5.72 | $0.92 | $0.95 | -96.38% |
| 2047 | $3.20 | $0.96 | $0.95 | -96.38% |
| 2048 | $1.04 | $1.04 | $0.94 | -96.41% |
| 2049 | $1.02 | $0.94 | $1.00 | -96.18% |
| 2050 | $0.94 | $1.09 | $1.06 | -95.96% |
| 2051 | $1.04 | $1.08 | $1.06 | -95.96% |
Pfizer Inc. (PFE) Stock Price Prediction & Forecast 2025
At the start of 2025, the PFE stock was at $26.09. Today, it is trading at $26.21, which is 0.46% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $50.69 by December 2025 with a 93.40% change.
Pfizer Inc. (PFE) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the PFE stock. During this period, the PFE's price is forecasted to shift from $56.05 to $41.59, which is -25.80% loss.
In 2026, the stock would possibly open at $56.05, descends to $51.23 by mid-year, and wraps up at $54.29, reflecting a 107.14% increase from today's price. Further moving to 2030, the stock can kick off the year at $44.37, drop to $38.47 by mid-year, and finish at $41.59, which is 58.70% change from current price.
Pfizer Inc. (PFE) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $40.32 to $16.46, which is down 45.31%
In 2031, we can expect PFE to fluctuate between $38.08 and $40.32, a shift indicating a 45.31% gain by year-end compared to current price. And Until 2040, PFE can likely vary from $16.46 to $20.18. By the end of 2040, the stock could record a -37.19% fall from today's stock price.
Pfizer Inc. (PFE) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the PFE stock can see an a downturn from $17.60 to $1.06 in this period. In 2041, the stock can experience a low of $11.49 by mid-year, closing the year at $13.05. This results in a -56.15% decrease from today.
Moving towards the end of 2050, PFE is projected to open the year at $0.94. The stock may peak to $1.09 during mid-year and finish the year at $1.06. Compared to the stock's current price, this translates to an overall loss of -95.97% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
PFE Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | - | $59.28 | -0.56% ▼ | $58.39 ▲ |
| MRK | Merck & Co., Inc. | - | $87.87 | -3.93% ▼ | $146.41 ▲ |
| ABBV | AbbVie Inc. | - | $210.75 | 0.82% ▲ | $81.29 ▲ |
| NVO | Novo Nordisk A/S | - | $73.60 | -18.81% ▼ | $247.89 ▲ |
| LLY | Eli Lilly and Company | - | $738.21 | -10.62% ▼ | $130.57 ▲ |
Last updated Mar 20 at 7 AM
PFE : Buy, Sell Or Hold?
Analyst Ratings
Based on 21 analysts, 2 rated as a strong buy, 6 recommended a buy, 13 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 23 analysts, 3 analysts gave a strong buy rating, 8 a buy rating, 11 a hold rating, 1 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for PFE stock is Hold.Expert Analysis
According to PFE short-term and long-term forecast, Pfizer Inc. shares are projected to go down by 95.96%, and reach a value of $1.06 per share by 2050.
As per technical analysis, indicators show a Neutral sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, PFE has recorded 12/30 green days, which reflects a 54.54545454545454% positivity rate with a price volatility of 0.01%.
Plus, Price-to-Earnings (P/E) ratio of 18.588652 suggests that PFE stock is overvalued. So, Based on PFE prediction and analysis, it may be the best time to hold PFE stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "PFE” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.